Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Rowley

Showing results (91-100 of 126) with videos related to

Pageof 13
Sort By:
Current Pharmaceutical Design|November 17, 2004
Lipoproteins and diabetic microvascular complicationsA J Jenkins, K G Rowley, T J Lyons, et al.
Diabetes Care|December 28, 2002
A cross-sectional study of the effects of type 2 diabetes and other cardiovascular risk factors on structure and function of nonstenotic arteries of the lower limbDavid N O'Neal, George Dragicevic, Kevin G Rowley, et al.
The American Journal of Clinical Nutrition|September 22, 2001
Improvements in circulating cholesterol, antioxidants, and homocysteine after dietary intervention in an Australian Aboriginal communityK G Rowley, Q Su, M Cincotta, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|September 15, 2011
Long-wavelength sensitization of TiO2 by ruthenium diimine compounds with low-lying π* orbitalsPatrik G Johansson, John G Rowley, Atefeh Taheri, et al.
Public Health Nutrition|November 18, 2015
Nutritional predictors of successful chronic disease prevention for a community cohort in Central AustraliaJoanne N Luke, Rebecca Ritte, Kerin O'Dea, et al.
Advances in Microbial Physiology|May 3, 2016
Nitrous Oxide Metabolism in Nitrate-Reducing Bacteria: Physiology and Regulatory MechanismsM J Torres, J Simon, G Rowley, et al.
Diabetes & Vascular Disease Research|May 24, 2014
Plasma semicarbazide-sensitive amine oxidase activity in type 1 diabetes is related to vascular and renal function but not to glycaemiaAndrzej S Januszewski, Nick Mason, Connie S Karschimkus, et al.
Redox Report : Communications in Free Radical Research|April 12, 2003
Paraoxonase and other coronary risk factors in a community-based cohortJacob Cohen, Alicia J Jenkins, Connie Karschimkus, et al.
Clinical Science (London, England : 1979)|January 7, 2005
Oxidative stress and high-density lipoprotein function in Type I diabetes and end-stage renal diseaseGeorge Kalogerakis, Arthur M Baker, Steve Christov, et al.
Journal of Cardiovascular Pharmacology|March 1, 1991
Altered alpha 1-adrenoceptor-mediated responses in atria of rats with chronic left ventricular infarctionK G Rowley, L H Tung, G P Hodsman, et al.
Pageof 13

Showing results (91-100 of 126) with videos related to

Sort By:
Pageof 13
Current Pharmaceutical Design|November 17, 2004
Lipoproteins and diabetic microvascular complicationsA J Jenkins, K G Rowley, T J Lyons, et al.
Diabetes Care|December 28, 2002
A cross-sectional study of the effects of type 2 diabetes and other cardiovascular risk factors on structure and function of nonstenotic arteries of the lower limbDavid N O'Neal, George Dragicevic, Kevin G Rowley, et al.
The American Journal of Clinical Nutrition|September 22, 2001
Improvements in circulating cholesterol, antioxidants, and homocysteine after dietary intervention in an Australian Aboriginal communityK G Rowley, Q Su, M Cincotta, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|September 15, 2011
Long-wavelength sensitization of TiO2 by ruthenium diimine compounds with low-lying π* orbitalsPatrik G Johansson, John G Rowley, Atefeh Taheri, et al.
Public Health Nutrition|November 18, 2015
Nutritional predictors of successful chronic disease prevention for a community cohort in Central AustraliaJoanne N Luke, Rebecca Ritte, Kerin O'Dea, et al.
Advances in Microbial Physiology|May 3, 2016
Nitrous Oxide Metabolism in Nitrate-Reducing Bacteria: Physiology and Regulatory MechanismsM J Torres, J Simon, G Rowley, et al.
Diabetes & Vascular Disease Research|May 24, 2014
Plasma semicarbazide-sensitive amine oxidase activity in type 1 diabetes is related to vascular and renal function but not to glycaemiaAndrzej S Januszewski, Nick Mason, Connie S Karschimkus, et al.
Redox Report : Communications in Free Radical Research|April 12, 2003
Paraoxonase and other coronary risk factors in a community-based cohortJacob Cohen, Alicia J Jenkins, Connie Karschimkus, et al.
Clinical Science (London, England : 1979)|January 7, 2005
Oxidative stress and high-density lipoprotein function in Type I diabetes and end-stage renal diseaseGeorge Kalogerakis, Arthur M Baker, Steve Christov, et al.
Journal of Cardiovascular Pharmacology|March 1, 1991
Altered alpha 1-adrenoceptor-mediated responses in atria of rats with chronic left ventricular infarctionK G Rowley, L H Tung, G P Hodsman, et al.
Pageof 13